The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. (Q51350319)
Jump to navigation
Jump to search
scientific article published on 13 October 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. |
scientific article published on 13 October 2012 |
Statements
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis (English)
1 reference
A Campanati
G Ganzetti
A Damiani
L Sandroni
L Rosa
A Benedetti
13 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference